vs
Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $379.6M, roughly 1.6× DIVERSIFIED HEALTHCARE TRUST). Royalty Pharma plc runs the higher net margin — 34.4% vs -5.6%, a 40.0% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -0.0%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs 1.2%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
DHC vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $379.6M | $622.0M |
| Net Profit | $-21.2M | $214.2M |
| Gross Margin | — | — |
| Operating Margin | -12.6% | 62.4% |
| Net Margin | -5.6% | 34.4% |
| Revenue YoY | -0.0% | 4.8% |
| Net Profit YoY | 75.7% | 2.9% |
| EPS (diluted) | $-0.09 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $379.6M | $622.0M | ||
| Q3 25 | $388.7M | $609.3M | ||
| Q2 25 | $382.7M | $578.7M | ||
| Q1 25 | $386.9M | $568.2M | ||
| Q4 24 | $379.6M | $593.6M | ||
| Q3 24 | $373.6M | $564.7M | ||
| Q2 24 | $371.4M | $537.3M | ||
| Q1 24 | $370.8M | $568.0M |
| Q4 25 | $-21.2M | $214.2M | ||
| Q3 25 | $-164.0M | $288.2M | ||
| Q2 25 | $-91.6M | $30.2M | ||
| Q1 25 | $-9.0M | $238.3M | ||
| Q4 24 | $-87.4M | $208.2M | ||
| Q3 24 | $-98.7M | $544.0M | ||
| Q2 24 | $-97.9M | $102.0M | ||
| Q1 24 | $-86.3M | $4.8M |
| Q4 25 | -12.6% | 62.4% | ||
| Q3 25 | -43.4% | 70.1% | ||
| Q2 25 | -24.5% | 36.3% | ||
| Q1 25 | -2.7% | 94.0% | ||
| Q4 24 | -26.1% | 60.9% | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | -23.0% | 50.2% | ||
| Q1 24 | -23.7% | -13.0% |
| Q4 25 | -5.6% | 34.4% | ||
| Q3 25 | -42.2% | 47.3% | ||
| Q2 25 | -23.9% | 5.2% | ||
| Q1 25 | -2.3% | 41.9% | ||
| Q4 24 | -23.0% | 35.1% | ||
| Q3 24 | -26.4% | 96.3% | ||
| Q2 24 | -26.3% | 19.0% | ||
| Q1 24 | -23.3% | 0.8% |
| Q4 25 | $-0.09 | $0.49 | ||
| Q3 25 | $-0.68 | $0.67 | ||
| Q2 25 | $-0.38 | $0.07 | ||
| Q1 25 | $-0.04 | $0.55 | ||
| Q4 24 | $-0.37 | $0.46 | ||
| Q3 24 | $-0.41 | $1.21 | ||
| Q2 24 | $-0.41 | $0.23 | ||
| Q1 24 | $-0.36 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $105.4M | $618.7M |
| Total DebtLower is stronger | $2.4B | $9.0B |
| Stockholders' EquityBook value | $1.7B | $9.7B |
| Total Assets | $4.4B | $19.6B |
| Debt / EquityLower = less leverage | 1.47× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $105.4M | $618.7M | ||
| Q3 25 | $201.4M | $938.9M | ||
| Q2 25 | $141.8M | $631.9M | ||
| Q1 25 | $302.6M | $1.1B | ||
| Q4 24 | $144.6M | $929.0M | ||
| Q3 24 | $256.5M | $950.1M | ||
| Q2 24 | $265.6M | $1.8B | ||
| Q1 24 | $207.1M | $843.0M |
| Q4 25 | $2.4B | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | $3.1B | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
| Q4 25 | $1.7B | $9.7B | ||
| Q3 25 | $1.7B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.9B | $9.8B | ||
| Q4 24 | $2.0B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.2B | $9.9B |
| Q4 25 | $4.4B | $19.6B | ||
| Q3 25 | $4.7B | $19.3B | ||
| Q2 25 | $4.8B | $18.3B | ||
| Q1 25 | $5.0B | $17.6B | ||
| Q4 24 | $5.1B | $18.2B | ||
| Q3 24 | $5.3B | $18.0B | ||
| Q2 24 | $5.3B | $17.7B | ||
| Q1 24 | $5.3B | $16.1B |
| Q4 25 | 1.47× | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 1.56× | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-19.6M | $827.1M |
| Free Cash FlowOCF − Capex | $-166.4M | — |
| FCF MarginFCF / Revenue | -43.8% | — |
| Capex IntensityCapex / Revenue | 38.7% | — |
| Cash ConversionOCF / Net Profit | — | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-280.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-19.6M | $827.1M | ||
| Q3 25 | $-49.3M | $702.6M | ||
| Q2 25 | $53.0M | $364.0M | ||
| Q1 25 | $-3.2M | $596.1M | ||
| Q4 24 | $112.2M | $742.5M | ||
| Q3 24 | $21.1M | $703.6M | ||
| Q2 24 | $44.3M | $658.2M | ||
| Q1 24 | $28.6M | $664.6M |
| Q4 25 | $-166.4M | — | ||
| Q3 25 | $-89.8M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-42.9M | — | ||
| Q4 24 | $-89.5M | — | ||
| Q3 24 | $-26.1M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-18.1M | — |
| Q4 25 | -43.8% | — | ||
| Q3 25 | -23.1% | — | ||
| Q2 25 | 4.9% | — | ||
| Q1 25 | -11.1% | — | ||
| Q4 24 | -23.6% | — | ||
| Q3 24 | -7.0% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | -4.9% | — |
| Q4 25 | 38.7% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.9% | — | ||
| Q1 25 | 10.2% | — | ||
| Q4 24 | 53.1% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 12.6% | — |
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
